Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of GNR-068 vs Stelara in Healthy Volunteers
NCT06481215Phase 1Completed
- Sponsor
- Generium
- Start
- Mar 2022
- Primary completion
- Sep 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ustekinumab in plaque psoriasis (2 arms), sponsored by Generium. Primary endpoints: Area under the plasma concentration versus time curve at Day 84 and Peak Plasma Concentration at Day 84. Started Mar 2022; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06481215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06481215.